Clinical trial NCT01856205 - References

Japanese Encephalitis — Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis

Citation(s)

•   Abraham CS, Deli MA, Joo F, Megyeri P, Torpier G
  Intracarotid tumor necrosis factor-alpha administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis. Neurosci Lett. 1996 Apr 19;208(2):85-8.
•   Agrawal AG, Petersen LR
  Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis. 2003 Jul 1;188(1):1-4. Epub 2003 Jun 23.
•   Allan SM, Rothwell NJ
  Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci. 2003 Oct 29;358(1438):1669-77. Review.
•   Atrasheuskaya A, Petzelbauer P, Fredeking TM, Ignatyev G
  Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):33-42.
•   Beasley DW, Li L, Suderman MT, Guirakhoo F, Trent DW, Monath TP, Shope RE, Barrett AD
  Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine. 2004 Sep 9;22(27-28):3722-6.
•   Ben-Nathan D, Lustig S, Tam G, Robinzon S, Segal S, Rager-Zisman B
  Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis. 2003 Jul 1;188(1):5-12. Epub 2003 Jun 23.
•   Bhowmick S, Duseja R, Das S, Appaiahgiri MB, Vrati S, Basu A
  Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci Lett. 2007 Feb 27;414(1):45-50. Epub 2007 Jan 8.
•   Bista MB, Banerjee MK, Shin SH, Tandan JB, Kim MH, Sohn YM, Ohrr HC, Tang JL, Halstead SB
  Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet. 2001 Sep 8;358(9284):791-5.
•   Bista MB, Shrestha JM
  Epidemiological situation of Japanese encephalitis in Nepal. JNMA J Nepal Med Assoc. 2005 Apr-Jun;44(158):51-6.
•   Brett FM, Mizisin AP, Powell HC, Campbell IL
  Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol. 1995 Nov;54(6):766-75.
•   Buchwald B, Ahangari R, Weishaupt A, Toyka KV
  Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome. Ann Neurol. 2002 Jun;51(6):673-80.
•   Burke DS, Lorsomrudee W, Leake CJ, Hoke CH, Nisalak A, Chongswasdi V, Laorakpongse T
  Fatal outcome in Japanese encephalitis. Am J Trop Med Hyg. 1985 Nov;34(6):1203-10.
•   Burke DS, Nisalak A, Lorsomrudee W, Ussery MA, Laorpongse T
  Virus-specific antibody-producing cells in blood and cerebrospinal fluid in acute Japanese encephalitis. J Med Virol. 1985 Nov;17(3):283-92.
•   Burke DS, Nisalak A, Ussery MA, Laorakpongse T, Chantavibul S
  Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis. 1985 Jun;151(6):1093-9.
•   Caramello P, Canta F, Balbiano R, Lipani F, Ariaudo S, De Agostini M, Calleri G, Boglione L, Di Caro A
  Role of intravenous immunoglobulin administration in Japanese encephalitis. Clin Infect Dis. 2006 Dec 15;43(12):1620-1.
•   Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L
  The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 2001 Nov 23;294(5547):1731-5.
•   Chambers TJ, Diamond MS
  Pathogenesis of flavivirus encephalitis. Adv Virus Res. 2003;60:273-342. Review.
•   Chambers TJ, Hahn CS, Galler R, Rice CM
  Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649-88. Review.
•   Chatterjee S, Chattopadhyay D, Bhattacharya MK, Mukherjee B
  Serosurveillance for Japanese encephalitis in children in several districts of West Bengal, India. Acta Paediatr. 2004 Mar;93(3):390-3.
•   Chen WR, Rico-Hesse R, Tesh RB
  A new genotype of Japanese encephalitis virus from Indonesia. Am J Trop Med Hyg. 1992 Jul;47(1):61-9.
•   Chen WR, Tesh RB, Rico-Hesse R
  Genetic variation of Japanese encephalitis virus in nature. J Gen Virol. 1990 Dec;71 ( Pt 12):2915-22.
•   Clarkson SB, Bussel JB, Kimberly RP, Valinsky JE, Nachman RL, Unkeless JC
  Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med. 1986 May 8;314(19):1236-9.
•   Desai A, Shankar SK, Ravi V, Chandramuki A, Gourie-Devi M
  Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol. 1995;89(4):368-73.
•   Diamond MS, Klein RS
  West Nile virus: crossing the blood-brain barrier. Nat Med. 2004 Dec;10(12):1294-5.
•   Diamond MS, Shrestha B, Marri A, Mahan D, Engle M
  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003 Feb;77(4):2578-86.
•   Doherty PC, Zinkernagel RM
  T-cell-mediated immunopathology in viral infections. Transplant Rev. 1974;19(0):89-120. Review.
•   Dwyer JM
  Manipulating the immune system with immune globulin. N Engl J Med. 1992 Jan 9;326(2):107-16. Review.
•   Edelman R, Schneider RJ, Vejjajiva A, Pornpibul R, Voodhikul P
  Persistence of virus-specific IgM and clinical recovery after Japanese encephalitis. Am J Trop Med Hyg. 1976 Sep;25(5):733-8.
•   Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A
  On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol. 1989 Apr;19(4):689-94.
•   Gajanana A, Thenmozhi V, Samuel PP, Reuben R
  A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic. Bull World Health Organ. 1995;73(2):237-44.
•   German AC, Myint KS, Mai NT, Pomeroy I, Phu NH, Tzartos J, Winter P, Collett J, Farrar J, Barrett A, Kipar A, Esiri MM, Solomon T
  A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg. 2006 Dec;100(12):1135-45. Epub 2006 Jun 30.
•   Ghoshal A, Das S, Ghosh S, Mishra MK, Sharma V, Koli P, Sen E, Basu A
  Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia. 2007 Apr 1;55(5):483-96.
•   Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM
  Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med. 2005 Oct 17;202(8):1087-98.
•   Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM
  CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med. 2006 Jan 23;203(1):35-40. Epub 2006 Jan 17.
•   Gould EA
  Evolution of the Japanese serological group viruses. In: Mackenzie JS, Barrett AD, Deubel V, editors. Current Topics in Microbiology and Immunology: Japanese encephalitis and West Nile virus infections: Springer-Verlag; 2002. p. 391-404.
•   Griffin DE, Hardwick JM
  Perspective: virus infections and the death of neurons. Trends Microbiol. 1999 Apr;7(4):155-60. Review.
•   Griffin DE, Ubol S, Desprès P, Kimura T, Byrnes A
  Role of antibodies in controlling alphavirus infection of neurons. Curr Top Microbiol Immunol. 2001;260:191-200. Review.
•   Griffin DE
  Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol. 2003 Jun;3(6):493-502. Review.
•   Gupta AK, Lad VJ, Koshy AA
  Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies. Acta Virol. 2003;47(3):141-5.
•   HALSTEAD SB, GROSZ CR
  Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. Am J Hyg. 1962 Mar;75:190-201.
•   Hoke CH Jr, Vaughn DW, Nisalak A, Intralawan P, Poolsuppasit S, Jongsawas V, Titsyakorn U, Johnson RT
  Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis. 1992 Apr;165(4):631-7.
•   Imbach P
  Immune thrombocytopenic purpura and intravenous immunoglobulin. Cancer. 1991 Sep 15;68(6 Suppl):1422-5. Review.
•   Innis BL
  Japanese encephalitis. In: Porterfield JS, editor. Exotic Viral Infections. London: Chapman & Hall; 1995. p. 147-74.
•   Irani DN
  Central nervous system inflammation: can't live with it, can't live without it. Curr Opin Neurol. 2001 Jun;14(3):347-8.
•   Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, Pham SM, Zaki S, Lanciotti RS, Lance-Parker SE, DiazGranados CA, Winquist AG, Perlino CA, Wiersma S, Hillyer KL, Goodman JL, Marfin AA, Chamberland ME, Petersen LR; West Nile Virus in Transplant Recipients Investigation Team
  Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003 May 29;348(22):2196-203.
•   Johnson RT, Burke DS, Elwell M, Leake CJ, Nisalak A, Hoke CH, Lorsomrudee W
  Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol. 1985 Nov;18(5):567-73.
•   Keller MA, Stiehm ER
  Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 2000 Oct;13(4):602-14. Review.
•   Kimura T, Griffin DE
  Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus. Virology. 2003 Jun 20;311(1):28-39.
•   Kimura-Kuroda J, Yasui K
  Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol. 1988 Nov 15;141(10):3606-10.
•   Konishi E, Ajiro N, Nukuzuma C, Mason PW, Kurane I
  Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine. 2003 Sep 8;21(25-26):3675-83.
•   Kreil TR, Eibl MM
  Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model. J Virol. 1997 Apr;71(4):2921-7.
•   Kumar R, Mathur A, Kumar A, Sharma S, Chakraborty S, Chaturvedi UC
  Clinical features & prognostic indicators of Japanese encephalitis in children in Lucknow (India). Indian J Med Res. 1990 Sep;91:321-7.
•   Leis AA, Stokic DS, Polk JL, Dostrow V, Winkelmann M
  A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med. 2002 Oct 17;347(16):1279-80. Epub 2002 Sep 23.
•   Leung DY, Burns JC, Newburger JW, Geha RS
  Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest. 1987 Feb;79(2):468-72.
•   Levine B, Hardwick JM, Trapp BD, Crawford TO, Bollinger RC, Griffin DE
  Antibody-mediated clearance of alphavirus infection from neurons. Science. 1991 Nov 8;254(5033):856-60.
•   Li Y, Fu L, Gonzales DM, Lavi E
  Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J Virol. 2004 Apr;78(7):3398-406.
•   Li ZS, Hong SF, Gong NL
  Immunohistochemical study on Japanese B encephalitis. Chin Med J (Engl). 1988 Oct;101(10):768-71.
•   Libraty DH, Nisalak A, Endy TP, Suntayakorn S, Vaughn DW, Innis BL
  Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg. 2002 Mar-Apr;96(2):173-8.
•   Liu T, Chambers TJ
  Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes. J Virol. 2001 Mar;75(5):2107-18.
•   Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L
  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002 May;8(5):500-8.
•   McMinn PC
  The molecular basis of virulence of the encephalitogenic flaviviruses. J Gen Virol. 1997 Nov;78 ( Pt 11):2711-22. Review.
•   MIYAKE M
  THE PATHOLOGY OF JAPANESE ENCEPHALITIS. A REVIEW. Bull World Health Organ. 1964;30:153-60. Review.
•   Monath TP
  Japanese encephalitis vaccines: current vaccines and future prospects. Curr Top Microbiol Immunol. 2002;267:105-38. Review.
•   Morrey JD, Siddharthan V, Olsen AL, Roper GY, Wang H, Baldwin TJ, Koenig S, Johnson S, Nordstrom JL, Diamond MS
  Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. J Infect Dis. 2006 Nov 1;194(9):1300-8. Epub 2006 Sep 22.
•   Morrey JD, Siddharthan V, Olsen AL, Wang H, Julander JG, Hall JO, Li H, Nordstrom JL, Koenig S, Johnson S, Diamond MS
  Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model. Antimicrob Agents Chemother. 2007 Jul;51(7):2396-402. Epub 2007 Apr 23.
•   Morris MM, Dyson H, Baker D, Harbige LS, Fazakerley JK, Amor S
  Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J Neuroimmunol. 1997 Apr;74(1-2):185-97.
•   Muñoz-Fernández MA, Fresno M
  The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol. 1998 Oct;56(3):307-40. Review.
•   Murali-Krishna K, Ravi V, Manjunath R
  Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells. J Gen Virol. 1996 Apr;77 ( Pt 4):705-14.
•   Myint KS, Gibbons RV, Perng GC, Solomon T
  Unravelling the neuropathogenesis of Japanese encephalitis. Trans R Soc Trop Med Hyg. 2007 Oct;101(10):955-6. Epub 2007 Jun 4. Review.
•   Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, et al
  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991 Jun 6;324(23):1633-9.
•   Ooi MH, Wong SC, Clear D, Perera D, Krishnan S, Preston T, Tio PH, Willison HJ, Tedman B, Kneen R, Cardosa MJ, Solomon T
  Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia. Clin Infect Dis. 2003 Mar 1;36(5):550-9. Epub 2003 Feb 14.
•   Pan CH, Chen HW, Huang HW, Tao MH
  Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses. J Virol. 2001 Dec;75(23):11457-63.
•   Pant GR
  A serological survey of pigs, horses, and ducks in Nepal for evidence of infection with Japanese encephalitis virus. Ann N Y Acad Sci. 2006 Oct;1081:124-9.
•   Paul R, Koedel U, Winkler F, Kieseier BC, Fontana A, Kopf M, Hartung HP, Pfister HW
  Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain. 2003 Aug;126(Pt 8):1873-82. Epub 2003 Jun 23.
•   Planitzer CB, Modrof J, Kreil TR
  West Nile virus neutralization by US plasma-derived immunoglobulin products. J Infect Dis. 2007 Aug 1;196(3):435-40. Epub 2007 Jun 18.
•   Quartier P, Foray S, Casanova JL, Hau-Rainsard I, Blanche S, Fischer A
  Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. Pediatr Infect Dis J. 2000 Nov;19(11):1106-8.
•   Ravi V, Parida S, Desai A, Chandramuki A, Gourie-Devi M, Grau GE
  Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol. 1997 Feb;51(2):132-6.
•   Rayamajhi A, Singh R, Prasad R, Khanal B, Singhi S
  Clinico-laboratory profile and outcome of Japanese encephalitis in Nepali children. Ann Trop Paediatr. 2006 Dec;26(4):293-301.
•   Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA
  Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997 Mar;99(3):454-61.
•   Rowell JF, Griffin DE
  Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis. J Neuroimmunol. 2002 Jun;127(1-2):106-14.
•   Shankar SK, Rao TV, Mruthyunjayanna BP, Gourie Devi M, Deshpande DH
  Autopsy study of brains during an epidemic of Japanese encephalitis in Karnataka. Indian J Med Res. 1983 Sep;78:431-40.
•   Shope RE
  Concepts of control of Japanese encephalitis and dengue. Southeast Asian J Trop Med Public Health. 1997;28 Suppl 2:131-4.
•   Singh A, Kulshreshtha R, Mathur A
  Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection. J Med Microbiol. 2000 Jul;49(7):607-12.
•   Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT
  Japanese encephalitis. J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):405-15.
•   Solomon T, Dung NM, Kneen R, Thao le TT, Gainsborough M, Nisalak A, Day NP, Kirkham FJ, Vaughn DW, Smith S, White NJ
  Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 2002 May;125(Pt 5):1084-93.
•   Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ
  Neurological manifestations of dengue infection. Lancet. 2000 Mar 25;355(9209):1053-9.
•   Solomon T, Dung NM, Wills B, Kneen R, Gainsborough M, Diet TV, Thuy TT, Loan HT, Khanh VC, Vaughn DW, White NJ, Farrar JJ
  Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet. 2003 Mar 8;361(9360):821-6.
•   Solomon T, Kneen R, Dung NM, Khanh VC, Thuy TT, Ha DQ, Day NP, Nisalak A, Vaughn DW, White NJ
  Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet. 1998 Apr 11;351(9109):1094-7.
•   Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD
  Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol. 2003 Mar;77(5):3091-8.
•   Solomon T, Thao LT, Dung NM, Kneen R, Hung NT, Nisalak A, Vaughn DW, Farrar J, Hien TT, White NJ, Cardosa MJ
  Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J Clin Microbiol. 1998 Jul;36(7):2030-4.
•   Solomon T, Vaughn DW
  Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol. 2002;267:171-94. Review.
•   Solomon T, Winter PM
  Neurovirulence and host factors in flavivirus encephalitis--evidence from clinical epidemiology. Arch Virol Suppl. 2004;(18):161-70. Review.
•   Solomon T
  Flavivirus encephalitis. N Engl J Med. 2004 Jul 22;351(4):370-8. Review.
•   Solomon T
  Japanese encephalitis: Clinical features & pathogenesis. 55th Annual Meeting of the American Society of Tropical Medicine and Hygiene; 2006; Atlanta, Georgia; 2006.
•   Solomon T
  Vaccines against Japanese encephalitis. In: Jong EC, Zuckerman JN, editors. Travelers' vaccines. Ontario, Canada: B.C. Decker; 2004. p. 219-56.
•   Spector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, Bryson YJ, Dankner WM, Livingston RA, Connor EM
  A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med. 1994 Nov 3;331(18):1181-7.
•   Sullivan KM, Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, Counts GW, Bowden RA, Peterson FB, Witherspoon RP, et al
  Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med. 1990 Sep 13;323(11):705-12.
•   Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, Kikuchi Y, Nagamatu H, Igarashi A
  Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology. 1987 Dec;161(2):497-510.
•   Tandan JB, Ohrr H, Sohn YM, Yoksan S, Ji M, Nam CM, Halstead SB
  Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com. Vaccine. 2007 Jun 28;25(27):5041-5. Epub 2007 May 8.
•   Tsai TF
  New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine. 2000 May 26;18 Suppl 2:1-25.
•   Van Wagoner NJ, Benveniste EN
  Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol. 1999 Dec;100(1-2):124-39. Review.
•   Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA
  Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004 Dec;10(12):1366-73. Epub 2004 Nov 21.
•   Wang Y, Lobigs M, Lee E, Müllbacher A
  CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol. 2003 Dec;77(24):13323-34.
•   Webb DB, Kendra JR, Gross E, Stamatakis JD
  Infusion of intravenous immunoglobulin via implantable subcutaneous catheter. Lancet. 1991 Jun 29;337(8757):1617-8.
•   Winter PM, Dung NM, Loan HT, Kneen R, Wills B, Thu le T, House D, White NJ, Farrar JJ, Hart CA, Solomon T
  Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis. 2004 Nov 1;190(9):1618-26. Epub 2004 Sep 29.
•   Zhang MJ, Wang MJ, Jiang SZ, Ma WY
  Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J Med Virol. 1989 Oct;29(2):133-8.

A Randomized Double Blind Placebo Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin (IVIG) in Children With Japanese Encephalitis in Nepal

Details for clinical trial NCT01856205